Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-21 · accession 0001786966-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-01-23 | 2026-01-21 | EWTX | Edris Badreddin | Dir | S - Sale+OE | $29.44 | -115.5K | 96.8K | -54% | -$3.40M |
| DMT | 2026-01-23 | 2026-01-21 | EWTX | Edris Badreddin | Dir | M - OptEx | $1.47 | +115.5K | 127.7K | +945% | +$170.3K |
| DMT | 2026-01-23 | 2026-01-21 | EWTX | Edris Badreddin | Dir | M - OptEx | $0.00 | -115.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-21 | S | D | 13,690 | $29.44 | 121,601 | D | — | — | (F2) The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.77, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2026-01-21 | M | A | 7,605 | $0.71 | 135,291 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-21 | M | A | 10,463 | $1.93 | 61,209 | D | — | — | |
| 4 | Common | Common Stock | 2026-01-21 | M | A | 17,236 | $0.64 | 50,746 | D | — | — | |
| 5 | Common | Common Stock | 2026-01-21 | M | A | 13,690 | $0.39 | 33,510 | D | — | — | |
| 6 | Common | Common Stock | 2026-01-21 | M | A | 66,477 | $1.93 | 127,686 | D | — | — | |
| 7 | Common | Common Stock | 2026-01-21 | S | D | 66,477 | $29.44 | 19,820 | D | — | — | (F2) The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.77, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2026-01-21 | S | D | 10,463 | $29.44 | 86,297 | D | — | — | (F2) The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.77, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 9 | Common | Common Stock | 2026-01-21 | S | D | 17,236 | $29.44 | 104,365 | D | — | — | (F2) The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.77, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2026-01-21 | S | D | 7,605 | $29.44 | 96,760 | D | — | — | (F2) The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.77, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 11 | Derivative | Stock Option (Right to Buy) | 2026-01-21 | M | D | 66,477 | $0.00 | 0 | D | $1.93 · 2024-02-03 to 2031-02-03 | 66,477 Common Stock | |
| 12 | Derivative | Stock Option (Right to Buy) | 2026-01-21 | M | D | 13,690 | $0.00 | 0 | D | $0.39 · 2021-03-04 to 2028-04-26 | 13,690 Common Stock | |
| 13 | Derivative | Stock Option (Right to Buy) | 2026-01-21 | M | D | 17,236 | $0.00 | 0 | D | $0.64 · 2023-10-16 to 2029-11-14 | 17,236 Common Stock | |
| 14 | Derivative | Stock Option (Right to Buy) | 2026-01-21 | M | D | 7,605 | $0.00 | 0 | D | $0.71 · 2024-09-02 to 2030-09-01 | 7,605 Common Stock | |
| 15 | Derivative | Stock Option (Right to Buy) | 2026-01-21 | M | D | 10,463 | $0.00 | 0 | D | $1.93 · 2024-12-03 to 2030-12-15 | 10,463 Common Stock |